Literature DB >> 33389310

Laser and light-based therapies in the management of rosacea: an updated systematic review.

Husein Husein-ElAhmed1,2, Martin Steinhoff3,4,5,6,7.   

Abstract

Unlike other rosacea therapies which need daily takings or applications over long periods, the edge of lasers and light-based therapies (LLBT) is the limited number of sessions to achieve improvement. The proper selection of the adequate physical device in accordance with the patients' skin features and rosacea-related signs and symptoms should be considered and the management with physical sources should be updated as new data become available. This article reviews and discusses the current use of lasers and light-based therapies in rosacea with reference to all the available literature.This systematic review demonstrates the quality of evidence to support any recommendation on LLBT in rosacea is low-to-moderate. Among all the available devices, PDL holds the most robust evidence. Treatments options should be tailored for each specific clinical scenario as it is unlike that single modality results in complete resolution. Platforms that include two or more devices and combined therapies with topical agents are suitable and they warrant further investigations.
© 2021. Springer-Verlag London Ltd., part of Springer Nature.

Entities:  

Keywords:  Efficacy; Laser; Light-based therapies; Rosacea; Treatment

Year:  2021        PMID: 33389310     DOI: 10.1007/s10103-020-03200-1

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  96 in total

1.  Laser treatment of erythema and telangiectasia associated with rosacea.

Authors:  S M Clark; S W Lanigan; R Marks
Journal:  Lasers Med Sci       Date:  2002       Impact factor: 3.161

Review 2.  Light-based devices in the treatment of cutaneous vascular lesions: An updated review.

Authors:  Benjamin C Garden; Jerome M Garden; David J Goldberg
Journal:  J Cosmet Dermatol       Date:  2017-07-13       Impact factor: 2.696

3.  Treatment of facial telangiectasias with a diode-pumped Nd:YAG laser at 532 nm.

Authors:  D A Cassuto; D M Ancona; G Emanuelli
Journal:  J Cutan Laser Ther       Date:  2000-09

4.  Treatment of erythematotelangiectatic rosacea with the fractionation of high-fluence, long-pulsed 595-nm pulsed dye laser.

Authors:  Jin Ok Baek; Hoon Hur; Ha Ryeong Ryu; Jeong Soo Kim; Kyung Real Lee; Yu Ri Kim; Kwang Ho Choi
Journal:  J Cosmet Dermatol       Date:  2016-10-20       Impact factor: 2.696

5.  A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema.

Authors:  Nathan S Uebelhoer; Melissa A Bogle; Brigitte Stewart; Kenneth A Arndt; Jeffrey S Dover
Journal:  Dermatol Surg       Date:  2007-04       Impact factor: 3.398

Review 6.  Physical modalities for the treatment of rosacea.

Authors:  Maja A Hofmann; Percy Lehmann
Journal:  J Dtsch Dermatol Ges       Date:  2016-12       Impact factor: 5.584

7.  A comparison of four frequency-doubled Nd:YAG (532 nm) laser systems for treatment of facial telangiectases.

Authors:  D J Goldberg; J G Meine
Journal:  Dermatol Surg       Date:  1999-06       Impact factor: 3.398

8.  Effects of cryogen spray cooling and high radiant exposures on selective vascular injury during laser irradiation of human skin.

Authors:  James W Tunnell; David W Chang; Carol Johnston; Jorge H Torres; Charles W Patrick; Michael J Miller; Sharon L Thomsen; Bahman Anvari
Journal:  Arch Dermatol       Date:  2003-06

9.  Microvasculature can be selectively damaged using dye lasers: a basic theory and experimental evidence in human skin.

Authors:  R R Anderson; J A Parrish
Journal:  Lasers Surg Med       Date:  1981       Impact factor: 4.025

10.  Update on the management of rosacea.

Authors:  Allison P Weinkle; Vladyslava Doktor; Jason Emer
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-04-07
View more
  1 in total

1.  The effects of photobiomodulation therapy on inflammatory mediators, immune infiltration, and angiogenesis in a mouse model of rosacea.

Authors:  Shuwei Wu; Yaoxi Su; Lian Wang; Bensen Sun; Xian Jiang
Journal:  Ann Transl Med       Date:  2022-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.